![Bob Huang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bob Huang
Directeur/Membre du Conseil chez
Travecta Therapeutics Pte Ltd.
Profil
Bob Huang is currently the Director at Travecta Therapeutics Pte Ltd. and Investment Director at Seidler Equity Australia.
He holds a doctorate from The University of New South Wales and an MBA from The Wharton School of the University of Pennsylvania.
Postes actifs de Bob Huang
| Sociétés | Poste | Début |
|---|---|---|
Seidler Equity Australia
 Seidler Equity Australia Investment ManagersFinance Acts as an alternative investment manager | Private Equity Investor | 01/01/2017 |
Travecta Therapeutics Pte Ltd.
 Travecta Therapeutics Pte Ltd. Packaged SoftwareTechnology Services Develops a novel chemistry platform for delivery of therapies to the brain | Directeur/Membre du Conseil | 27/10/2021 |
Formation de Bob Huang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
The University of New South Wales
 The University of New South Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Travecta Therapeutics Pte Ltd.
Travecta Therapeutics Pte Ltd. Packaged SoftwareTechnology Services Develops a novel chemistry platform for delivery of therapies to the brain | Technology Services |
Seidler Equity Australia
Seidler Equity Australia Investment ManagersFinance Acts as an alternative investment manager | Finance |
